Consistently, microarray analysis of prostate cancer profiles (GDS2546) in GEO datasets confirmed that SIRT6 mRNA level in metastasis site samples was remarkably increased compared with the normal or primary site tissues (Figure 1B). The gene discussed is SIRT6; the disease is prostate carcinoma.